Sensitive cationic lipids impurities analysis with quantitation by charged aerosol detection and simultaneous mass confirmation by MS

Significance of the Topic

Lipid nanoparticles (LNPs) are widely applied as delivery vehicles for nucleic acid therapeutics, including mRNA vaccines and siRNA. Cationic lipids represent a crucial component in LNP formulations, directly influencing transfection efficiency, stability, and safety. Accurate detection and quantification of trace impurities in cationic lipid raw materials are vital for ensuring product quality, regulatory compliance, and patient safety.

Objectives and Overview of the Study

This study aims to demonstrate the application of an inverse gradient liquid chromatography method combined with charged aerosol detection (CAD) and simultaneous mass confirmation by single quadrupole mass spectrometry (MS). Using three representative cationic lipids—R-DOTAP, DLin-KC2-DMA, and ALC-0315—the method’s sensitivity, quantitative accuracy, and repeatability were evaluated on a Thermo Scientific™ Vanquish™ Flex Inverse Gradient UHPLC system with a Charged Aerosol Detector HP and ISQ™ EM MS.

Methodology and Used Instrumentation

• Chromatography: Hypersil GOLD C8 column (3.0 × 100 mm, 3 µm); mobile phases of 5 mM ammonium formate in water/acetonitrile and methanol; inverse gradient profile to optimize impurity elution.
• Detection: Thermo Scientific™ Vanquish™ Charged Aerosol Detector HP operated with an active diverter valve to focus detector engagement on target analytes.
• Mass Confirmation: Thermo Scientific™ ISQ™ EM single quadrupole MS in positive electrospray ionization mode; scan range m/z 300–900 to enhance impurity signal-to-noise ratios.

Used Instrumentation

• Vanquish Flex UHPLC with Dual Pump F, Split Sampler FT, Column Compartment H, and Inverse Gradient Kit.
• Vanquish Charged Aerosol Detector HP.
• ISQ EM Single Quadrupole Mass Spectrometer.

Main Results and Discussion

• Sensitivity: CAD achieved limit of quantitation (LOQ) for minor impurity peaks (signal-to-noise ≥10) down to 0.023 mg/mL; MS channel displayed S/N >50 for the same impurities.
• Repeatability: Six replicate injections yielded %RSD ≤2.1% for CAD peak areas and heights, and ≤0.03% for retention times. MS confirmations showed %RSD ≤2.1% for peak area/height and ≤0.13% for retention time.
• Mass Confirmation: Single quadrupole MS validated unit mass of both cationic lipids and associated impurities, ensuring unambiguous identification across the m/z range.

Benefits and Practical Applications

• High Sensitivity: CAD provides robust quantitation of low-level impurities without reliance on chromophores.
• Regulatory Compliance: Chromeleon™ CDS integration supports data integrity and audit trails.
• Flexible Workflows: Inverse gradient coupling and diverter valve strategy maximize detector uptime and column reconditioning.
• Mass Confirmation: Parallel MS detection delivers rapid confirmation of impurity identities, reducing the need for reference standards.

Future Trends and Possibilities

• Expansion to Other Lipid Classes: Adapting the inverse gradient approach to neutral or zwitterionic lipids in complex formulations.
• High-Throughput Screening: Automation of sample preparation and parallel CAD-MS detection for increased laboratory efficiency.
• Regulatory Harmonization: Development of standardized impurity thresholds and method protocols across global guidelines.
• Integration with HRMS: Coupling with high-resolution mass spectrometers for structural elucidation of unknown lipid impurities.

Conclusion

The inverse gradient LC-CAD-MS method effectively quantifies trace impurities in cationic lipids with high sensitivity, accuracy, and reproducibility. The seamless integration of CAD and single quadrupole MS on the Vanquish Flex platform offers a powerful, compliance-ready workflow for quality control of lipid raw materials in pharmaceutical and biopharmaceutical development.

References

1. Thermo Fisher Scientific Application Note 003384: Quantifying impurities in cationic lipid raw materials with the inverse gradient method using LC-CAD-MS.
2. Albertsen C. et al. The role of lipid components in lipid nanoparticles for vaccines and gene therapy. Adv Drug Deliv Rev. 2022;188:114416.
3. Birdsall R. et al. Monitoring stability indicating impurities and aldehyde content in lipid nanoparticle raw material and formulated drugs. J Chromatogr B. 2024;1234:124005.